Apollo Hospitals [APOLLOHOSP] vs Fortis Healthcare [FORTIS] Detailed Stock Comparison

Apollo Hospitals
NSE
Loading...

Fortis Healthcare
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Apollo Hospitals wins in 11 metrics, Fortis Healthcare wins in 9 metrics, with 0 ties. Apollo Hospitals appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Apollo Hospitals | Fortis Healthcare | Better |
---|---|---|---|
P/E Ratio (TTM) | 73.17 | 83.50 | Apollo Hospitals |
Price-to-Book Ratio | 12.87 | 7.28 | Fortis Healthcare |
Debt-to-Equity Ratio | 90.89 | 26.99 | Fortis Healthcare |
PEG Ratio | 90.09 | 67.08 | Fortis Healthcare |
EV/EBITDA | 36.80 | 44.65 | Apollo Hospitals |
Profit Margin (TTM) | 6.63% | 9.94% | Fortis Healthcare |
Operating Margin (TTM) | 9.99% | 16.19% | Fortis Healthcare |
EBITDA Margin (TTM) | 9.99% | 16.19% | Fortis Healthcare |
Return on Equity | 18.85% | 9.13% | Apollo Hospitals |
Return on Assets (TTM) | 7.57% | 5.54% | Apollo Hospitals |
Free Cash Flow (TTM) | $4.24B | $5.77B | Fortis Healthcare |
Dividend Yield | 0.27% | 0.12% | Apollo Hospitals |
1-Year Return | 9.56% | 69.91% | Fortis Healthcare |
Price-to-Sales Ratio (TTM) | 4.85 | 8.33 | Apollo Hospitals |
Enterprise Value | $1,112.00B | $669.56B | Apollo Hospitals |
EV/Revenue Ratio | 5.10 | 8.60 | Apollo Hospitals |
Gross Profit Margin (TTM) | 47.63% | 56.28% | Fortis Healthcare |
Revenue per Share (TTM) | $1,516 | $103 | Apollo Hospitals |
Earnings per Share (Diluted) | $100.47 | $10.29 | Apollo Hospitals |
Beta (Stock Volatility) | 0.28 | 0.64 | Apollo Hospitals |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Apollo Hospitals vs Fortis Healthcare Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Apollo Hospitals | -0.59% | -1.57% | -1.93% | 6.11% | 7.71% | -0.25% |
Fortis Healthcare | 0.31% | 1.62% | 10.91% | 25.72% | 37.07% | 21.28% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Apollo Hospitals | 9.56% | 68.07% | 321.72% | 411.62% | 1,741.56% | 3,793.80% |
Fortis Healthcare | 69.91% | 224.98% | 522.64% | 348.23% | 456.15% | 754.98% |
Performance & Financial Health Analysis: Apollo Hospitals vs Fortis Healthcare
Metric | APOLLOHOSP | FORTIS |
---|---|---|
Market Information | ||
Market Cap | ₹1.06T | ₹648.70B |
Market Cap Category | Large cap | Large cap |
10 Day Avg. Volume | 331,835 | 1,973,726 |
90 Day Avg. Volume | 461,715 | 1,723,231 |
Last Close | ₹7,308.00 | ₹861.90 |
52 Week Range | ₹6,001.00 - ₹7,635.00 | ₹480.55 - ₹867.35 |
% from 52W High | -4.28% | -0.63% |
All-Time High | ₹552,030.00 (Nov 20, 2023) | ₹867.35 (Aug 01, 2025) |
% from All-Time High | -98.68% | -0.63% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.13% | 0.12% |
Quarterly Earnings Growth | 0.54% | 0.03% |
Financial Health | ||
Profit Margin (TTM) | 0.07% | 0.10% |
Operating Margin (TTM) | 0.10% | 0.16% |
Return on Equity (TTM) | 0.19% | 0.09% |
Debt to Equity (MRQ) | 90.89 | 26.99 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹571.24 | ₹118.11 |
Cash per Share (MRQ) | ₹194.24 | ₹6.70 |
Operating Cash Flow (TTM) | ₹21.36B | ₹14.24B |
Levered Free Cash Flow (TTM) | ₹1.37B | ₹-15,062,938,624 |
Dividends | ||
Last 12-Month Dividend Yield | 0.27% | 0.12% |
Last 12-Month Dividend | ₹19.00 | ₹1.00 |
Valuation & Enterprise Metrics Analysis: Apollo Hospitals vs Fortis Healthcare
Metric | APOLLOHOSP | FORTIS |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 73.17 | 83.50 |
Forward P/E | 90.09 | 67.08 |
PEG Ratio | 90.09 | 67.08 |
Price to Sales (TTM) | 4.85 | 8.33 |
Price to Book (MRQ) | 12.87 | 7.28 |
Market Capitalization | ||
Market Capitalization | ₹1.06T | ₹648.70B |
Enterprise Value | ₹1.11T | ₹669.56B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 5.10 | 8.60 |
Enterprise to EBITDA | 36.80 | 44.65 |
Risk & Other Metrics | ||
Beta | 0.28 | 0.64 |
Book Value per Share (MRQ) | ₹571.24 | ₹118.11 |
Financial Statements Comparison: Apollo Hospitals vs Fortis Healthcare
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | APOLLOHOSP | FORTIS |
---|---|---|
Revenue/Sales | ₹55.92B | ₹20.07B |
Cost of Goods Sold | ₹29.29B | ₹8.78B |
Gross Profit | ₹26.64B | ₹11.30B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹5.59B | ₹3.33B |
EBITDA | ₹8.41B | ₹4.60B |
Pre-Tax Income | ₹5.16B | ₹2.37B |
Income Tax | ₹1.01B | ₹485.30M |
Net Income (Profit) | ₹4.15B | ₹1.88B |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | APOLLOHOSP | FORTIS |
---|---|---|
Cash & Equivalents | ₹5.78B | ₹1.40B |
Total Current Assets | ₹70.29B | ₹14.71B |
Total Current Liabilities | ₹45.79B | ₹16.07B |
Long-Term Debt | ₹68.31B | ₹23.11B |
Total Shareholders Equity | ₹86.53B | ₹91.69B |
Retained Earnings | N/A | N/A |
Property, Plant & Equipment | ₹98.16B | ₹58.48B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | APOLLOHOSP | FORTIS |
---|---|---|
Operating Cash Flow | N/A | ₹163.49M |
Capital Expenditures | N/A | ₹-275.51M |
Free Cash Flow | N/A | ₹-200.43M |
Debt Repayment | N/A | ₹-1.81B |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | APOLLOHOSP | FORTIS |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 331,835 | 1,973,726 |
Average Daily Volume (90 Day) | 461,715 | 1,723,231 |
Shares Outstanding | 143.78M | 754.96M |
Float Shares | 98.37M | 488.93M |
% Held by Insiders | 0.30% | 0.04% |
% Held by Institutions | 0.48% | 0.80% |
Dividend Analysis & Yield Comparison: Apollo Hospitals vs Fortis Healthcare
Metric | APOLLOHOSP | FORTIS |
---|---|---|
Last 12-Month Dividend | ₹19.00 | ₹1.00 |
Last 12-Month Dividend Yield | 0.27% | 0.12% |
3-Year Avg Annual Dividend | ₹20.25 | ₹1.00 |
3-Year Avg Dividend Yield | 0.17% | 0.21% |
3-Year Total Dividends | ₹60.75 | ₹3.00 |
Ex-Dividend Date | Feb 14, 2025 | Jul 25, 2025 |